rallies

JHVEPhoto Humacyte (NASDAQ:HUMA) stock rallied 19% Monday on news that the company has received FDA regenerative medicine advanced therapy, or RMAT, designation for its product candidate Acellular Tissue Engineered Vessel, or ATEV, for the treatment of peripheral artery disease. The biotech company noted it was the third RMAT designation forContinue Reading

Aleksandra Zhilenkova Fly-E Group (NASDAQ:FLYE) soared 30% in early afternoon trading and hit a new post-IPO high of $7.42 earlier in the session. The electric vehicle company priced its IPO on June 6 at $4.00 per share, which was at the low end of the original expected range of $4.00Continue Reading